394 related articles for article (PubMed ID: 18067646)
1. Transfusion-transmitted infections among multitransfused patients in Iran: a review.
Rezvan H; Abolghassemi H; Kafiabad SA
Transfus Med; 2007 Dec; 17(6):425-33. PubMed ID: 18067646
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of transfusion associated infections in multitransfused children in relation to mandatory screening of HIV in donated blood.
Aggarwal V; Prakash C; Yadav S; Chattopadhya D
Southeast Asian J Trop Med Public Health; 1997 Dec; 28(4):699-706. PubMed ID: 9656388
[TBL] [Abstract][Full Text] [Related]
3. Prevalence and risk factors of hepatitis C virus, hepatitis B virus, and human immunodeficiency virus in multiply transfused recipients in Mexico.
Calderón GM; González-Velázquez F; González-Bonilla CR; Novelo-Garza B; Terrazas JJ; Martínez-Rodríguez ML; Cortés-Márquez SR; Blanco-Flores JP; Rodríguez-Rodríguez A; Del Campo MA; Cortés-Gómez R; Mejía-Bocanegra MG
Transfusion; 2009 Oct; 49(10):2200-7. PubMed ID: 19538543
[TBL] [Abstract][Full Text] [Related]
4. Transfusion-dependent thalassemia: viral complications (epidemiology and follow-up).
de Montalembert M; Girot R; Mattlinger B; Lefrère JJ
Semin Hematol; 1995 Oct; 32(4):280-7. PubMed ID: 8560285
[No Abstract] [Full Text] [Related]
5. Prevalence and trends of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus among blood donors in Iran, 2004 through 2007.
Kafi-abad SA; Rezvan H; Abolghasemi H; Talebian A
Transfusion; 2009 Oct; 49(10):2214-20. PubMed ID: 19527477
[TBL] [Abstract][Full Text] [Related]
6. SEN and hepatitis virus infections in nontransfused children and pediatric thalassemia patients with multiple transfusions in Taiwan.
Chiou SS; Huang JF; Chang TT; Hsieh MY; Dai CY; Yu ML; Chang WY; Chuang WL
Digestion; 2006; 74(3-4):208-14. PubMed ID: 17341855
[TBL] [Abstract][Full Text] [Related]
7. Clinical spectrum of viral infections in hemophilic patients.
Telfer MC
Hematol Oncol Clin North Am; 1992 Oct; 6(5):1047-56. PubMed ID: 1328142
[TBL] [Abstract][Full Text] [Related]
8. Preventing transfusion-transmitted infections: issues related to migrating populations and increasing world travel.
Sandler SG; Fang C
Haematologia (Budap); 1991; 24(4):197-210. PubMed ID: 1688227
[TBL] [Abstract][Full Text] [Related]
9. Transfusion-transmitted infectious diseases.
Allain JP; Stramer SL; Carneiro-Proietti AB; Martins ML; Lopes da Silva SN; Ribeiro M; Proietti FA; Reesink HW
Biologicals; 2009 Apr; 37(2):71-7. PubMed ID: 19231236
[TBL] [Abstract][Full Text] [Related]
10. Seroepidemiology of human T-cell lymphotropic virus among Iranian adult thalassemic patients.
Keshvari M; Hajibeigi B; Azarkeivan A; Keyvani H; Behnava B; Saiedi Hosseini SY; Sharafi H; Alavian SM
Transfus Med; 2014 Aug; 24(4):227-32. PubMed ID: 25124072
[TBL] [Abstract][Full Text] [Related]
11. Surveillance for transfusion-transmitted viral infections in the United States.
Chamberland ME
Biologicals; 1998 Jun; 26(2):85-8. PubMed ID: 9811510
[TBL] [Abstract][Full Text] [Related]
12. Legal, financial, and public health consequences of transfusion-transmitted hepatitis C virus in persons with haemophilia.
Angelotta C; McKoy JM; Fisher MJ; Buffie CG; Barfi K; Ramsey G; Frohlich L; Bennett CL
Vox Sang; 2007 Aug; 93(2):159-65. PubMed ID: 17683360
[TBL] [Abstract][Full Text] [Related]
13. Transfusion-associated infections: 50 years of relentless challenges and remarkable progress.
Perkins HA; Busch MP
Transfusion; 2010 Oct; 50(10):2080-99. PubMed ID: 20738828
[No Abstract] [Full Text] [Related]
14. Transfusion-transmitted virus prevalence in Turkish patients with thalassemia.
Ozyürek E; Ergünay K; Kuskonmaz B; Unal S; Cetin M; Ustaçelebi S; Gürgey A; Gümrük F
Pediatr Hematol Oncol; 2006 Jun; 23(4):347-53. PubMed ID: 16621777
[TBL] [Abstract][Full Text] [Related]
15. Profile of transfusion transmissible infections and associated risk factors among blood donors of Kerala.
Mathai J; Sulochana PV; Satyabhama S; Nair PK; Sivakumar S
Indian J Pathol Microbiol; 2002 Jul; 45(3):319-22. PubMed ID: 12785175
[TBL] [Abstract][Full Text] [Related]
16. Trends in transfusion-transmitted viral infections from 2001 to 2006 in Ibadan, Nigeria.
Fasola FA; Kotila TR; Akinyemi JO
Intervirology; 2008; 51(6):427-31. PubMed ID: 19321928
[TBL] [Abstract][Full Text] [Related]
17. [Residual infectious risk of blood transfusion].
Janot C; Botté C
Cah Anesthesiol; 1994; 42(3):357-60. PubMed ID: 7812862
[No Abstract] [Full Text] [Related]
18. Impact of individual-donation nucleic acid testing on risk of human immunodeficiency virus, hepatitis B virus, and hepatitis C virus transmission by blood transfusion in South Africa.
Vermeulen M; Lelie N; Sykes W; Crookes R; Swanevelder J; Gaggia L; Le Roux M; Kuun E; Gulube S; Reddy R
Transfusion; 2009 Jun; 49(6):1115-25. PubMed ID: 19309474
[TBL] [Abstract][Full Text] [Related]
19. The significance of the blood-borne viruses: blood banking and transfusion medicine.
Sherwood WC
Dev Biol Stand; 1993; 81():25-33. PubMed ID: 8174810
[TBL] [Abstract][Full Text] [Related]
20. [The risk of transfusion-induced virus infection].
Mörike EM
Dtsch Med Wochenschr; 1996 Sep; 121(39):A8. PubMed ID: 8925741
[No Abstract] [Full Text] [Related]
[Next] [New Search]
